INMB
INmune Bio Inc
Halal Rating :
Last Price
$6.46
Last updated:
Market Cap
-
7D Change
-1.22%
1 Year Change
-42.17%
Company Overview
Industries
Exchange
Next Earnings Date
INmune Bio Inc is a clinical-stage immunotherapy company developing treatments that target the innate immune system. The company focuses on developing therapies for diseases like cancer, Alzheimer's disease, and treatment-resistant depression. Their main product candidates include INKmune, a natural killer cell therapeutic for cancer treatment, and XPro1595, targeting neuroinflammation in Alzheimer's disease.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| March 31, 2024 | $14000.0 | $11.04m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate INmune Bio Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.